Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evolent Health Q2 Adj. EPS $(0.10) Compared With $0.18 YoY, Sales $444.328M Miss $459.430M Estimate

Author: Benzinga Newsdesk | August 07, 2025 04:13pm
Evolent Health (NYSE:EVH) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.09 by 214.94 percent. This is a 133.33 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $444.328 million which missed the analyst consensus estimate of $459.430 million by 3.29 percent. This is a 31.34 percent decrease over sales of $647.145 million the same period last year.

Posted In: EVH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist